A Novel Method to Study the Effects of Cyclosporine on Gingival Overgrowth in Children
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Previous studies to elucidate the etiology of cyclosporine(Cs)-induced gingival overgrowth in children have not completely excluded all factors that may cause differences among individuals. This study examined the effect of cyclosporine on the metabolism of type 1 collagen(CoL-I) in experimental models that controlled the effects of biological variations on individuals. Five 5-week-old male Sprague-Dawley rats were administered Cs by gastric feeding for 6 weeks. Gingival specimens were harvested from the mandibular posterior area before beginning Cs administration and at 2, 4, and 6 weeks thereafter. Gingival fibroblasts were cultured from all the 20 biopsies collected from the gingiva. Half of the fibroblasts collected prior to the Cs administration were designated as Control. The other half of the fibroblasts were treated with Cs in vitro and called in vitro test group(Tt). The fibroblasts collected 2, 4, and 6 weeks after the Cs administration were called in vivo test groups : T2, T4, T6, respectively. Immunofluorescence microscopy was used to detect CoL-I in all the fibroblasts. CoL-I was analyzed at both the gene and protein expression levels by real-time polymerase chain reaction and western blotting. Changes in CoL-I before and after Cs treatment were evaluated from the gingiva of each rat. There was no significant difference in gene expression of CoL-I in the control and test groups. CoL-I protein expression levels of fibroblasts increased in in vitro Cs treatment for each individual, and also increased in in vivo Cs treatment. In this study, the experimental method that control biological variations that can occur due to differences among individuals was useful. Subsequent studies on other factors besides CoL-I and in-depth studies in humans are needed.
Abstract
Previous studies to elucidate the etiology of cyclosporine(Cs)-induced gingival overgrowth in children have not completely excluded all factors that may cause differences among individuals. This study examined the effect of cyclosporine on the metabolism of type 1 collagen(CoL-I) in experimental models that controlled the effects of biological variations on individuals. Five 5-week-old male Sprague-Dawley rats were administered Cs by gastric feeding for 6 weeks. Gingival specimens were harvested from the mandibular posterior area before beginning Cs administration and at 2, 4, and 6 weeks thereafter. Gingival fibroblasts were cultured from all the 20 biopsies collected from the gingiva. Half of the fibroblasts collected prior to the Cs administration were designated as Control. The other half of the fibroblasts were treated with Cs in vitro and called in vitro test group(Tt). The fibroblasts collected 2, 4, and 6 weeks after the Cs administration were called in vivo test groups : T2, T4, T6, respectively. Immunofluorescence microscopy was used to detect CoL-I in all the fibroblasts. CoL-I was analyzed at both the gene and protein expression levels by real-time polymerase chain reaction and western blotting. Changes in CoL-I before and after Cs treatment were evaluated from the gingiva of each rat. There was no significant difference in gene expression of CoL-I in the control and test groups. CoL-I protein expression levels of fibroblasts increased in in vitro Cs treatment for each individual, and also increased in in vivo Cs treatment. In this study, the experimental method that control biological variations that can occur due to differences among individuals was useful. Subsequent studies on other factors besides CoL-I and in-depth studies in humans are needed.
참고문헌 (28)
- Kahan BD, "Cyclosporine", N Engl J Med, 321, pp.1725~1738 (1989)[DOI]
- Karpinia KA, "Factors affecting cyclosporine-induced gingival overgrowth in pediatric renal transplant recipients", Pediatr Dent, 18, pp.450~455 (1996)
- Bolzani G, "Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts", J Periodontal Res, 35, pp.51~58 (2000)[DOI]
- Kataoka M, "Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth", J Cell Physiol, 182, pp.351~358 (2000)[DOI]
- Jiko M, "Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats", Pharm Res, 19, pp.1362~1367 (2002)[DOI]
- Oh SA, "Collagen three-dimensional hydrogel matrix carrying basic fibroblast growth factor for the cultivation of mesenchymal stem cells and osteogenic differentiation", Tissue Eng Part A, 18, pp.1087~1100 (2012)[DOI]
- Hyland PL, "The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts", J Periodontol, 74, pp.437~445 (2003)[DOI]
- Dannewitz B, "Elevation of collagen type I in fibroblast-keratinocyte cocultures emphasizes the decisive role of fibroblasts in the manifestation of the phenotype of cyclosporin A-induced gingival overgrowth", J Periodontal Res, 44, pp.62~72 (2009)[DOI]
- Yang X, "Hard tissue formation of STRO-1-selected rat dental pulp stem cells in vivo", Tissue Eng Part A, 15, pp.367~375 (2009)[DOI]
- Oh SA, "Effects on growth and osteogenic differentiation of mesenchymal stem cells by the zinc-added sol-gel bioactive glass granules", J Tissue Eng, 2010, pp.475260~ (2011)
- Nam S, "Odontogenic differentiation of human dental pulp stem cells stimulated by the calcium phosphate porous granules", J Tissue Eng, 2011, pp.812547~ (2011)
- Nishikawa S, "Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model", J Periodontol, 67, pp.463~471 (1996)[DOI]
- Kataoka M, "Drug-induced gingival overgrowth-a review", Biol Pharm Bull, 28, pp.1817~1821 (2005)[DOI]
- Hassell TM, "Drug-induced gingival overgrowth: old problem, new problem", Crit Rev Oral Biol Med, 2, pp.103~137 (1991)[DOI]
- Gagliano N, "Immunosuppression and gingival overgrowth: gene and protein expression profiles of collagen turnover in FK506-treated human gingival fibroblasts", J Clin Periodontol, 32, pp.167~173 (2005)[DOI]
- Dannewitz B, "Elevated levels of gene expression for collagen and decorin in human gingival overgrowth", J Clin Periodontol, 33, pp.510~516 (2006)[DOI]
- Tipton DA, "Fibroblast heterogeneity in collagenolytic response to cyclosporine", J Cell Biochem, 46, pp.152~165 (1991)[DOI]
- Gagliano N, "Effect of cyclosporin A on human gingival fibroblast collagen turnover in relation to the development of gingival overgrowth: an in vitro study", Biomed Pharmacother, 58, pp.231~238 (2004)[DOI]
- Stefanovic B, "Regulatory role of the conserved stem-loop structure at the 5' end of collagen alpha1(I) mRNA", Mol Cell Biol, 19, pp.4334~4342 (1999)[DOI]
- Stefanovic B, "Inhibition of collagen alpha1(I) expression by the 5' stem-loop as a molecular decoy", J Biol Chem, 277, pp.18229~18237 (2002)[DOI]
- Slack JL, "An upstream regulatory region mediates high-level, tissue-specific expression of the human alpha1(I) collagen gene in transgenic mice", Mol Cell Biol, 11, pp.2066~2074 (1991)[DOI]
- Stefanovic B, "RNA protein interactions governing expression of the most abundant protein in human body, type I collagen", Wiley Interdiscip Rev RNA, 4, pp.535~545 (2013)[DOI]
- Rippe RA, "Methods for assessing the molecular mechanisms controlling gene regulation", Method Mol Med, 117, pp.141~160 (2005)
- Stefanovic B, "The 5' stem-loop regulates expression of collagen alpha1(I) mRNA in mouse fibroblasts cultured in a three-dimensional matrix", Nucleic Acids Res, 28, pp.641~647 (2000)[DOI]
- Kitamura K, "Gingival overgrowth induced by cyclosporin A in rats", Arch Oral Biol, 35, pp.483~486 (1990)[DOI]
- Morisaki I, "Age dependency of cyclosporin A-induced gingival overgrowth in rats", Pediatr Dent, 15, pp.414~417 (1993)
- Morisaki I, "Positive correlation between blood cyclosporin A level and severity of gingival overgrowth in rats", J Periodontol, 68, pp.7~11 (1997)[DOI]
- Ishida H, "Factors influencing nifedipine-induced gingival overgrowth in rats", J Periodontol, 66, pp.345~350 (1995)[DOI]